Today: 16 May 2026
AMD stock in focus as Lisa Su’s $75 million award and insider trades land in filings
19 February 2026
1 min read

AMD stock in focus as Lisa Su’s $75 million award and insider trades land in filings

New York, February 19, 2026, 14:06 (EST) — Regular session

Advanced Micro Devices climbed 0.7% to $201.46 Thursday afternoon, trading in a band from $198.40 up to $203.95. Shares tacked on roughly $1.34 from the previous close of $200.12.

Why it matters now: Lately, AMD’s stock has been reacting to even slight hints tied to its ambitions in data-center AI chips—investors are watching for hard evidence on orders, launch dates, and customer commitment. In a market fixated on “growth,” details like executive compensation and insider moves often get scrutinized as signals, no matter if that’s warranted.

The filings land while chipmakers remain hypersensitive to any major AI infrastructure decisions by their big clients. Just one procurement headline—regardless of its actual impact on near-term revenue—can send sentiment sharply in either direction.

According to a Form 4 filed Wednesday, CFO Jean Hu unloaded 19,956 shares on Feb. 17, with share prices between roughly $196.78 and $205.12. The trades happened as part of a 10b5-1 plan, allowing scheduled insider transactions. The same filing disclosed that 30,788 restricted stock units vested on Feb. 15; 11,416 shares went toward tax withholding. Afterward, Hu was left with 24,948 shares held directly, the filing said.

General Counsel Ava Hahn, according to another filing, reported a planned sale of 286 shares for a total of $56,813.90. The sale is set under a 10b5-1 plan adopted in June 2025. The same Form 144 notes a January transaction involving 2,442 shares.

AMD is moving ahead on its Helios data center plan in India, partnering with Tata Consultancy Services to back as much as 200 megawatts of AI infrastructure, the firms said. “AI adoption is accelerating from pilots to large-scale deployments,” CEO Lisa Su noted in the statement. Taipei Times

Pressure in the market is heating up. Nvidia announced this week it’s entered a multiyear deal to deliver millions of AI chips to Meta Platforms, including both existing models and those still to come. The company also plans to provide central processors—directly challenging Intel and AMD on that front.

Still, when it comes to the bear case, execution and timing are front and center — and rumors can bite before the numbers even start to shift. Tom’s Hardware flagged that AMD shot down talk of a delay to its next-gen Instinct MI455X ramp, citing corporate vice president Anush Elangovan, who told them Helios systems remain “on target for 2H 2026.” Tom’s Hardware

Earlier, AMD disclosed in an SEC filing that its board had signed off on 2025 cash performance bonuses for senior executives and a special “CEO Value Creation Equity Award” for Su, targeted at $75 million and scheduled for grant on March 15, 2026. The award comes in the form of performance-based restricted stock units—shares that only vest if certain price targets are hit. The highest payout links to AMD’s stock reaching $600 at any point before March 2031. Advanced Micro Devices, Inc.

Stock Market Today

  • Hedge Fund Appaloosa Sells Off Major Airline Stocks Amid Rising Fuel Costs
    May 15, 2026, 6:12 PM EDT. Hedge fund Appaloosa Capital has sold its entire stakes in the 'big three' U.S. airlines: Delta Air Lines, American Airlines, and United Airlines. This move comes as the airline industry contends with soaring fuel costs, a key expense that can erode profit margins. Instead, Appaloosa increased holdings in tech and transportation companies Amazon and Uber. The shift signals the hedge fund's reduced confidence in the airline sector's short-term outlook amid cost pressures, favoring firms poised for growth in e-commerce and ride-sharing markets.

Latest articles

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT delays annual meeting to June after AI-driven stock jump

AXT delays annual meeting to June after AI-driven stock jump

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Kitwave share price slips after margin warning as takeover vote draws closer
Previous Story

Kitwave share price slips after margin warning as takeover vote draws closer

Glencore stock today: Why the share price is steady after the $2 billion payout plan
Next Story

Glencore stock today: Why the share price is steady after the $2 billion payout plan

Go toTop